Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2768 - Health related quality of life and utility weights of Medical Oncology inpatients

Date

10 Sep 2017

Session

Poster display session

Topics

Cancers in Adolescents and Young Adults (AYA);  Bioethical Principles and GCP

Presenters

Maria Angeles Vicente Conesa

Citation

Annals of Oncology (2017) 28 (suppl_5): v395-v402. 10.1093/annonc/mdx375

Authors

M.A. Vicente Conesa, M. Zafra Poves, M.A. Ivars, I. Ballester, A. Carmona-Bayonas, F. Ayala de la Peña

Author affiliations

  • Hematology And Medical Oncology, Hospital Universitario Morales Meseguer, 30008 - Murcia/ES
More

Resources

Abstract 2768

Background

Health related quality of life (HRQoL) data and utilities derived from preference-based scales are needed for pharmacoeconomic studies. However, available data for hospitalized Medical Oncology patients are scarce or restricted to specific neoplasms. The aim of this work was to obtain health state utilities (HSU) from a heterogeneous population of cancer inpatients admitted to a Medical Oncology department.

Methods

Between Dec-15 and March-16, we prospectively collected HRQoL data from consecutive patients admitted to a Medical Oncology ward using EuroQoL 5-domains 5-levels instrument (EQ-5D-5L) and EQ-5D-5L visual analogic scale (VAS). Utility weights were assigned according to Spain social tariff using EuroQol crosswalk value sets. Non-parametric tests (Mann Whitney U, Kruskal-Wallis) were used to evaluate differences of HSU between groups.

Results

215 patients were included; median age: 62 (16-88); ECOG: 1 (45%), 2 (43%), 3-4 (12%); site: lung (27%), breast (15%), colorectal (15%), urogenital (15%); stage: I-II (11%), III (15%), IV (74%); active anticancer treatment: 87%; death during admission: 17 (8%). Mean (SD) EQ-5D-5L HSU for all patients was 0.52 (0.41); VAS: 52 (2). Mean (SD) values for EQ-5D-5L domains: mobility, 2.21 (1.24); self-care, 2.23 (1.49); usual activities, 2.89 (1.41); pain/discomfort, 1.94 (1.29); anxiety/depression: 2.12 (0.94). Differences between groups are shown in Table.Table:

1118P HRQoL values (mean) and differences according to clinical characteristics

Clinical characteristicsPatients (n = 215)EQ-5D-5L utilitypEQ-5D-5L VASp
ECOG 1 2 3-496 92 270.77 0.41 0.04

Conclusions

Average utility (EQ-5D-5L) for Medical Oncology inpatients is 0.52; lowest scores in this population were obtained for pain/discomfort and anxiety/depression domains. Significant differences were observed between different ECOG levels, tumor stages, admission causes and type of treatment.

Clinical trial identification

Legal entity responsible for the study

Francisco Ayala de la Peña

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.